Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica.

Tanaka Y, Takahashi T, Fukasawa T, Inokuchi S, Uenaka H, Fujita A, Shimamoto K, Sakamoto K

DOI: 10.1136/rmdopen-2025-005650
Published: 2025 Jul 25
Container: RMD open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2025-005650,
  title = {Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica.},
  author = {Tanaka Y and Takahashi T and Fukasawa T and Inokuchi S and Uenaka H and Fujita A and Shimamoto K and Sakamoto K},
  year = {2025},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2025-005650},
  url = {https://doi.org/10.1136/rmdopen-2025-005650}
}

RIS

TY  - JOUR
TI  - Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica.
AU  - Tanaka Y
AU  - Takahashi T
AU  - Fukasawa T
AU  - Inokuchi S
AU  - Uenaka H
AU  - Fujita A
AU  - Shimamoto K
AU  - Sakamoto K
PY  - 2025
JO  - RMD open
DO  - 10.1136/rmdopen-2025-005650
UR  - https://doi.org/10.1136/rmdopen-2025-005650
ER  -

APA

Y, T., T, T., T, F., S, I., H, U., A, F., K, S., & K, S. (2025). Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica.. RMD open. https://doi.org/10.1136/rmdopen-2025-005650

Source records

pubmed · retrieved 2026-09-27T10:48:47.968Z